Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Novo Nordisk A/S (NVO)

52.24 0.4 (0.77%)

11-24 13:02

Open:

51.98

Pre. Close:

51.84

High:

52.32

Low:

51.91

Volume:

494,247

Market Cap:

128545M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

51.8 - 52.29

52.29 - 53.03

Low:

50.68 - 51.11

51.11 - 51.77

Close:

51.26 - 51.79

51.79 - 52.58

Technical analysis  (as of: 2017-11-24 1:58:26 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 61.11     One year: 71.38

Support:

Support1: 50.13    Support2: 48.77

Resistance:

Resistance1: 52.32    Resistance2: 61.11

Pivot:

50.44

Moving Averages:

MA(5): 51.63     MA(20): 50.25

MA(100): 47.06     MA(250): 41.20

MACD:

MACD(12,26): 0.65     Signal(12,26,9): 0.44

%K %D:

%K(14,3): 96.30     %D(3): 95.08

RSI:

RSI(14): 69.34

52-Week:

High: 52.32  Low: 31.91  Change(%): 60.5

Average Vol(K):

3-Month: 197924  10-Days 112394

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVO has closed below upper band by 1.5%. Bollinger Bands are 26.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 10 Jun 2017 10:07:11 GMT
Why Novo Nordisk A/S (ADR) Jumped 10.6% In May

Tue, 22 Nov 2016 16:55:25 GMT
Portfolio Update - Novo Nordisk Purchased

Fri, 24 Nov 2017 15:33:45 GMT
What's Novo Nordisk AS (ADR) (NVO) Upside After Touching 52-Week High?

Wed, 06 Sep 2017 14:26:15 GMT
Here's Why Novo Nordisk A/S Gained 12% in August

Mon, 14 Aug 2017 20:15:00 GMT
Novo Nordisk results: The raw numbers

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

Shares Float (M)

1770.00

% Held by Insiders

0.02

% Held by Institutions

7.90

Shares Short (K)

4580

Shares Short Prior Month (K)

5140

Stock Financials

EPS

2.490

EPS Est. Current Year

2.420

EPS Est. Next Year

2.590

EPS Est. Next Quarter

0.530

Forward EPS

2.590

Book Value (p.s.)

3.150

PEG Ratio

2.59

Profit Margin

33.81

Operating Margin

44.59

Return on Assets (ttm)

34.2

Return on Equity (ttm)

84.8

Qtrly Rev. Growth

4.3

Gross Profit (p.s.)

38.145

Sales Per Share

7.435

EBITDA (p.s.)

3.504

Qtrly Earnings Growth

-0.20

Operating Cash Flow (M)

7840.00

Levered Free Cash Flow (M)

4370.00

FoxReading.com

Valuation

P/E

20.98

P/E Growth Ratio

0.01

P/BV

16.58

P/S

7.03

P/CF

Dividend Yield

0.02

Dividends & Splits

Dividend

1.230

Dividend Pay Date

2017-08-29

Ex-Dividend Date

2017-08-17

Forward Dividend

0.950

Last Split Date

2014-01-09

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.